Dr Neil Portman

Dr Neil Portman completed his PhD in the field of molecular cell biology at the University of Oxford, UK. He worked on the single-celled eukaryotic parasite Trypanosoma brucei, etiological agent of African sleeping sickness, with a particular focus on the cytoskeleton and flagellum. He moved to the University of Sydney in 2012 after being awarded a Vice Chancellor’s postdoctoral fellowship to continue his interest in the biology of the eukaryotic flagellum in another model of parasitic disease, the apicomplexan.

After a short career break being a full-time dad, he joined the Connie Johnson Breast Cancer Research Group at the Garvan Institute of Medical Research where he is applying his background in molecular biology, genome editing and proteomics techniques to generate and interrogate models of endocrine resistant breast cancer with the aim of identifying novel therapeutic strategies to improve outcomes for patients with advanced breast cancer.